These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26795703)

  • 41. Cannabis Policy Changes and Adolescent Cannabis Use: Evidence from Europe.
    Benedetti E; Resce G; Brunori P; Molinaro S
    Int J Environ Res Public Health; 2021 May; 18(10):. PubMed ID: 34068202
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug law reform, performativity and the politics of childhood.
    Flacks SJ
    Int J Drug Policy; 2018 Jan; 51():56-66. PubMed ID: 29202316
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The challenges in developing a rational cannabis policy.
    Hall W; Lynskey M
    Curr Opin Psychiatry; 2009 May; 22(3):258-62. PubMed ID: 19293714
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence-based policy? The re-medicalization of cannabis and the role of expert committees in the UK, 1972-1982.
    Taylor SL
    Int J Drug Policy; 2016 Nov; 37():129-135. PubMed ID: 27477790
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Observations of the role of science in the United States medical cannabis state policies: Lessons learnt.
    Grbic J; Goddard P; Ryder D
    Int J Drug Policy; 2017 Apr; 42():109-114. PubMed ID: 28190671
    [TBL] [Abstract][Full Text] [Related]  

  • 46. From failed global drug prohibition to regulating the drug market.
    Wodak A
    Addiction; 2018 Jul; 113(7):1225-1226. PubMed ID: 29883025
    [No Abstract]   [Full Text] [Related]  

  • 47. Policy recommendations and cost implications for a more sustainable framework for European human biomonitoring surveys.
    Joas A; Knudsen LE; Kolossa-Gehring M; Sepai O; Casteleyn L; Schoeters G; Angerer J; Castaño A; Aerts D; Biot P; Horvat M; Bloemen L; Reis MF; Lupsa IR; Katsonouri A; Cerna M; Berglund M; Crettaz P; Rudnai P; Halzlova K; Mulcahy M; Gutleb AC; Fischer ME; Becher G; Fréry N; Jensen G; Van Vliet L; Koch HM; Den Hond E; Fiddicke U; Esteban M; Exley K; Schwedler G; Seiwert M; Ligocka D; Hohenblum P; Kyrtopoulos S; Botsivali M; DeFelip E; Guillou C; Reniero F; Grazuleviciene R; Veidebaum T; Mørck TA; Nielsen JK; Jensen JF; Rivas TC; Sanchez J; Koppen G; Smolders R; Kozepesy S; Hadjipanayis A; Krskova A; Mannion R; Jakubowski M; Fucic JA; Pereira-Miguel J; Gurzau AE; Jajcaj M; Mazej D; Tratnik JS; Lehmann A; Larsson K; Dumez B; Joas R
    Environ Res; 2015 Aug; 141():42-57. PubMed ID: 25526891
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adding a dedicated public health approach to the international drug control regime.
    Tinasti K; Crocket A; Buechli DS
    J Public Health Policy; 2015 May; 36(2):248-50. PubMed ID: 25811388
    [No Abstract]   [Full Text] [Related]  

  • 49. Security, development and human rights: normative, legal and policy challenges for the international drug control system.
    Barrett D
    Int J Drug Policy; 2010 Mar; 21(2):140-4. PubMed ID: 20116987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Politics of Universal Health Coverage in Low- and Middle-Income Countries: A Framework for Evaluation and Action.
    Fox AM; Reich MR
    J Health Polit Policy Law; 2015 Oct; 40(5):1023-60. PubMed ID: 26195606
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug legalisation.
    Farrell M
    BMJ; 2014 Aug; 349():g5233. PubMed ID: 25146248
    [No Abstract]   [Full Text] [Related]  

  • 52. [Cannabis--narcotic conventions, legislation and legislative debate].
    Hartelius J
    Lakartidningen; 1976 Nov; 73(45):3879-81. PubMed ID: 979457
    [No Abstract]   [Full Text] [Related]  

  • 53. International institutions and China's health policy.
    Huang Y
    J Health Polit Policy Law; 2015 Feb; 40(1):41-71. PubMed ID: 25480846
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Trends and issues in the international drug control system--Vienna 2003.
    Room R
    J Psychoactive Drugs; 2005 Dec; 37(4):373-83. PubMed ID: 16480164
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SDGs will not be achieved without drug policy reform.
    Tinasti K; Bém P; Grover A; Kazatchkine M; Dreifuss R
    Lancet; 2015 Sep; 386(9999):1132. PubMed ID: 26461896
    [No Abstract]   [Full Text] [Related]  

  • 56. As I see it. Africa not to blame for AIDS.
    Ochieng P
    New Afr; 1987 Jan; (232):25. PubMed ID: 12317102
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overview of regulatory/policy/economic issues related to carbon dioxide.
    Leaf D; Verolme HJ; Hunt WF
    Environ Int; 2003 Jun; 29(2-3):303-10. PubMed ID: 12676217
    [TBL] [Abstract][Full Text] [Related]  

  • 58. International control of alcohol: alternative paths forward.
    Room R
    Drug Alcohol Rev; 2006 Nov; 25(6):581-95. PubMed ID: 17132575
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Progress in global blood safety for HIV.
    Takei T; Amin NA; Schmid G; Dhingra-Kumar N; Rugg D
    J Acquir Immune Defic Syndr; 2009 Dec; 52 Suppl 2():S127-31. PubMed ID: 19901625
    [TBL] [Abstract][Full Text] [Related]  

  • 60. International drug control governance: Is a joint UN programme on drugs relevant?
    Tinasti K
    Int J Drug Policy; 2020 Mar; 77():102687. PubMed ID: 32007681
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.